KEGG: kla:KLLA0A00660g
STRING: 284590.XP_451027.1
ATG32 is a transmembrane protein essential for mitochondrial autophagy (mitophagy) in yeast. It serves as a receptor protein that confers selectivity for mitochondrial sequestration as cargo during the autophagy process. In yeast systems, ATG32 is specifically required for mitophagy but not for other types of selective autophagy or for non-specific macroautophagy . The protein localizes to the outer membrane of mitochondria with its N-terminal domain exposed to the cytosol and C-terminal domain in the mitochondrial intermembrane space . Following mitophagy induction, ATG32 binds to ATG11, an adaptor protein for selective types of autophagy, and is subsequently recruited to and imported into the vacuole along with mitochondria . This process is essential for mitochondrial quality and quantity control, which is evolutionarily conserved from yeast to humans .
For optimal preservation of recombinant K. lactis ATG32 protein activity, researchers should follow these storage and handling protocols:
Store lyophilized protein at -20°C/-80°C upon receipt
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
Add glycerol to a final concentration of 5-50% (optimally 50%) for long-term storage
Aliquot the reconstituted protein to avoid repeated freeze-thaw cycles
For short-term use, working aliquots can be stored at 4°C for up to one week
Avoid repeated freezing and thawing as this can compromise protein integrity
The protein is typically supplied in a Tris/PBS-based buffer containing 6% trehalose at pH 8.0, which helps maintain stability during storage .
Recombinant ATG32 serves as a valuable tool for investigating mitophagy mechanisms through several experimental approaches:
Interaction studies: Purified recombinant ATG32 can be used in pull-down assays, surface plasmon resonance, or isothermal titration calorimetry to quantitatively measure binding affinities with partners like ATG8 and ATG11 .
Structural analysis: The protein can be utilized for crystallography studies, as demonstrated with the ATG32 AIM peptide binding to ATG8, providing insights into the molecular interface of these interactions .
Reconstitution experiments: Researchers can design in vitro systems with purified components to reconstitute early events in mitophagy initiation, particularly focusing on complex formation between ATG32, ATG8, and ATG11 .
Domain function analysis: By creating truncated or chimeric constructs, researchers can determine which domains are necessary and sufficient for specific functions, similar to experiments showing that the cytosolic domain of ATG32 can direct autophagy machinery to peroxisomes when artificially targeted there .
These applications provide mechanistic insights into how ATG32 functions as an autophagic degron and initiates assembly of core ATG proteins on the mitochondrial surface .
Several robust methods can be employed to monitor and quantify ATG32-dependent mitophagy:
GFP processing assay: This semi-quantitative method employs mitochondrial proteins tagged with GFP (e.g., Om45-GFP). During mitophagy, these fusion proteins are delivered to the vacuole where the GFP moiety is cleaved but remains relatively stable. The accumulation of free GFP can be monitored by western blot, with the ratio of free GFP to the full-length fusion protein indicating the level of mitophagy .
Fluorescence microscopy: Mitochondrially-targeted fluorescent proteins like mito-DHFR-mCherry can be used to visualize the translocation of mitochondria to the vacuole. Colocalization with vacuolar membrane markers (e.g., Vph1-mCherry) confirms mitophagy .
Biochemical fractionation: Following mitophagy induction, researchers can isolate vacuoles and analyze the presence of mitochondrial proteins by western blotting to quantify mitophagy.
Electron microscopy: This technique allows direct visualization of mitochondria within autophagosomes or vacuoles.
The effectiveness of these methods can be verified using positive controls (wild-type cells) and negative controls (atg1Δ or atg11Δ mutants, which are defective in autophagy) .
While specific conditions for K. lactis are not directly addressed in the provided search results, mitophagy induction conditions in yeast generally include:
Respiratory growth followed by nitrogen starvation: Cells are first grown in medium containing a non-fermentable carbon source (e.g., lactate or glycerol) to promote mitochondrial proliferation and then shifted to nitrogen starvation medium (SD-N) .
Post-logarithmic phase growth in lactate medium: Extended growth in lactate medium (YPL) past the logarithmic phase induces mitophagy .
Upregulation of ATG32 expression: Growth in glycerol medium increases ATG32 protein levels 10-20 fold compared to glucose-grown cells, which facilitates mitophagy .
For experiments specifically with K. lactis, researchers should adapt these protocols based on the physiology of this yeast species, potentially adjusting carbon sources and starvation conditions to achieve optimal mitophagy induction.
ATG32 serves as a platform that recruits the core autophagy machinery to mitochondria through specific protein-protein interactions:
ATG8 interaction: ATG32 contains an ATG8-family interacting motif (AIM) that binds directly to ATG8, a ubiquitin-like protein that becomes conjugated to phosphatidylethanolamine (PE) in autophagosomes. This interaction is critical for efficient mitophagy, as mutations in the AIM (e.g., WQAI to AQAA) or in the AIM-binding interface of ATG8 (P52A/R67A) reduce mitophagy .
ATG11 interaction: ATG32 also binds ATG11, a scaffold protein required for selective autophagy. Following mitophagy induction, this interaction recruits ATG32-containing mitochondria to the phagophore assembly site. Variants of ATG32 that cannot stably interact with ATG11 show severe defects in mitochondrial degradation .
Complex formation: ATG32 forms a complex with ATG8 and ATG11 prior to and independent of isolation membrane generation and subsequent autophagosome formation, indicating that ATG32 acts at the earliest stages of mitophagy initiation .
X-ray crystallography has revealed that the ATG32 AIM peptide binds ATG8 in a conserved manner, providing structural insights into this key interaction .
The cytosolic domain of ATG32 plays a crucial role in mitophagy and has several important functions:
Sufficiency for mitophagy: The cytosolic domain alone is fully capable of targeting the core autophagy machinery to mitochondria, indicating that the intermembrane space (IMS) domain is dispensable for the basic mitophagy function .
Transferable degron activity: When artificially anchored to peroxisomes, the ATG32 cytosolic domain can promote autophagy-dependent peroxisome degradation (pexophagy), demonstrating that it contains a degron-like module capable of directing autophagy machinery to other organelles .
Protein interaction hub: This domain harbors the binding sites for both ATG8 (via the AIM) and ATG11, which are essential interactions for recruiting autophagy machinery .
Direct initiation of autophagosome formation: The cytosolic domain directly initiates assembly of core ATG proteins on the mitochondrial surface, acting as an autophagic degron specific for autophagy-dependent degradation .
These findings suggest that ATG32 is the sole mitochondrial protein necessary and sufficient to directly mediate mitophagy, with its cytosolic domain containing all essential functions for this process .
Mutations in the ATG8-binding motif of ATG32 have significant but complex effects on its function:
Reduction in ATG8 binding: The WQAI to AQAA mutation in the ATG8-family interacting motif (AIM) of ATG32 reduces binding to ATG8 in yeast two-hybrid systems, though some interaction is still detected in coimmunoprecipitation assays, suggesting additional protein-protein interfaces may contribute to ATG32-ATG8 interaction in vivo .
Mild mitophagy defects: Cells expressing ATG32 with the AQAA mutation show only mild defects in mitophagy, maintaining approximately 88% of wild-type levels .
Synthetic defects in combination with ATG8 mutations: When combined with mutations in the AIM-binding interface of ATG8 (P52A/R67A), the ATG32 AQAA mutation causes synthetic defects in mitochondrial degradation, reducing mitophagy to approximately 60% of wild-type levels .
Impact on pre-autophagosomal complex formation: These mutations affect the ability of ATG32 to efficiently form complexes with ATG8 and ATG11 prior to isolation membrane generation, demonstrating their importance in the early stages of mitophagy .
These findings suggest that the interaction between ATG32 and ATG8 is crucial for mitophagy and that the free form of ATG8 can bind ATG32 on the mitochondrial surface prior to its PE conjugation and membrane anchoring to autophagosomes .
To distinguish ATG32's specific role in mitophagy from other selective autophagy pathways, researchers can employ these experimental approaches:
Parallel pathway analysis: Researchers can simultaneously monitor different selective autophagy pathways in the same cells to determine specificity:
Genetic approaches:
Chimeric protein studies: By fusing the ATG32 cytosolic domain to peroxisomal targeting sequences, researchers demonstrated that this domain can promote pexophagy when artificially localized to peroxisomes, indicating its potential as a universal organelle-specific autophagy adaptor
Interaction profiling: Analyze protein interaction networks specific to each pathway to identify unique and shared components
These approaches have established that ATG32 is specifically required for mitophagy but not for other selective autophagy pathways or nonspecific macroautophagy .
Working with recombinant ATG32 presents several methodological challenges that researchers should consider:
Protein solubility and stability:
Post-translational modifications:
Challenge: E. coli-expressed recombinant protein lacks yeast-specific modifications
Solution: For studies requiring native modifications, consider expression in yeast systems or in vitro modification after purification
Functional assays:
Challenge: Determining if recombinant protein retains native activity
Solution: Develop in vitro reconstitution assays with purified components to test interactions and complex formation
Storage and handling:
Domain preservation:
Challenge: Ensuring the correct folding of functional domains
Solution: Validate protein structure and function through binding assays with known partners like ATG8 and ATG11
Addressing these challenges is crucial for obtaining reliable and reproducible results when working with recombinant ATG32 proteins.
To investigate evolutionary conservation of ATG32 function across yeast species, researchers can employ these experimental approaches:
Comparative sequence analysis:
Align ATG32 sequences from different yeast species (S. cerevisiae, K. lactis, etc.)
Identify conserved domains, motifs, and binding sites, particularly the AIM and ATG11-binding regions
Generate phylogenetic trees to understand evolutionary relationships
Complementation studies:
Express K. lactis ATG32 in S. cerevisiae atg32Δ mutants to test functional rescue
Quantify mitophagy restoration using established assays (GFP processing, microscopy)
Create chimeric proteins with domains from different species to map functional conservation
Structural biology approaches:
Compare crystal structures of AIM peptides from different species binding to ATG8
Conduct structural analysis of ATG32-ATG11 interactions across species
Interactome analysis:
Perform comparative proteomics to identify ATG32 interaction partners in different yeast species
Use techniques like BioID or proximity labeling to map the protein neighborhood of ATG32
Functional domain swapping:
Create hybrid proteins with domains from different species to identify functionally interchangeable regions
Test these constructs in appropriate functional assays
These approaches would help determine whether ATG32's role as an autophagic degron and direct initiator of mitophagy is indeed a "common molecular feature in mitochondria autophagy conserved from yeast to humans" as suggested by research findings .
To ensure high-quality recombinant ATG32 protein preparations for experimental use, researchers should evaluate these critical parameters:
Purity assessment:
Protein folding and integrity:
Circular dichroism (CD) spectroscopy: Assess secondary structure
Fluorescence spectroscopy: Evaluate tertiary structure
Size exclusion chromatography: Detect aggregation or oligomerization
Functional validation:
Binding assays: Confirm interaction with ATG8 and ATG11
ATPase activity (if applicable): Measure enzymatic activity
Thermal shift assays: Assess protein stability
Contaminant testing:
Endotoxin testing: Particularly important for immunological studies
Nucleic acid contamination: Measure A260/A280 ratio
Protease activity: Test for proteolytic contaminants
Storage stability:
Freeze-thaw stability: Test activity after multiple freeze-thaw cycles
Temperature sensitivity: Compare activity at different storage temperatures
Buffer optimization: Assess stability in different buffer formulations
The product information indicates that commercially available recombinant K. lactis ATG32 protein typically has >90% purity as determined by SDS-PAGE , which serves as a basic quality control benchmark.
When troubleshooting experiments involving ATG32-mediated mitophagy, researchers should consider these common issues and solutions:
Additionally, researchers should include appropriate controls in every experiment:
Wild-type cells (positive control)
atg1Δ (negative control for all autophagy)
atg11Δ (negative control for selective autophagy)
Several expression systems can be employed for producing functional recombinant ATG32, each with distinct advantages for different experimental applications:
E. coli expression system:
Advantages: High yield, cost-effective, simple culture conditions
Best for: Cytosolic domain expression, structural studies, binding assays
Limitations: Lacks post-translational modifications, potential folding issues for membrane proteins
Current commercial production uses this system with N-terminal His tags
Yeast expression systems:
Advantages: Native post-translational modifications, proper folding of yeast proteins
Best for: Full-length ATG32 including transmembrane domain, functional studies
Options: S. cerevisiae (well-characterized), K. lactis (potentially better for K. lactis ATG32)
Limitations: Lower yield than bacterial systems, more complex purification
Insect cell expression:
Advantages: Eukaryotic processing, good for membrane proteins
Best for: Full-length ATG32, complex formation studies
Limitations: More expensive, technically demanding
Cell-free expression systems:
Advantages: Rapid, allows toxic protein expression, direct incorporation of modified amino acids
Best for: Domain mapping, interaction studies, incorporation of biophysical probes
Limitations: Typically lower yield, higher cost
Several cutting-edge research questions remain to be fully addressed regarding ATG32 function:
Regulation of ATG32 expression and activity:
How is ATG32 upregulated 10-20 fold during respiratory growth?
What are the transcriptional regulators and signaling pathways involved?
Are there post-translational modifications that regulate ATG32 activity?
Structural determinants of selectivity:
What structural features allow ATG32 to function as an organelle-specific adaptor?
How does the structural arrangement of ATG32-ATG8-ATG11 complexes promote specific mitochondrial recognition?
Conservation and evolution:
Are there functional homologs of ATG32 in higher eukaryotes?
How have mitophagy receptors evolved across species?
Role in mitochondrial quality control:
How does ATG32 distinguish damaged from healthy mitochondria?
Is there a mechanism for selective targeting of dysfunctional mitochondrial regions?
Integration with other cellular pathways:
How does ATG32-mediated mitophagy coordinate with mitochondrial fission/fusion?
What is the relationship between ATG32 and other stress response pathways?
Degron-like properties:
Can the ATG32 cytosolic domain be engineered to target other cellular components for selective autophagy?
What are the minimal structural requirements for this degron function?
The finding that ATG32's cytosolic domain can promote autophagy of other organelles when artificially localized there opens possibilities for engineering selective autophagy receptors for biotechnological and therapeutic applications .
Advanced imaging techniques offer powerful approaches to investigate ATG32 function with unprecedented spatial and temporal resolution:
Super-resolution microscopy:
Stimulated emission depletion (STED) microscopy can visualize ATG32 distribution on the mitochondrial surface below the diffraction limit
Photoactivated localization microscopy (PALM) and stochastic optical reconstruction microscopy (STORM) can map ATG32 clustering during mitophagy initiation
These techniques could reveal if ATG32 forms distinct microdomains on mitochondria during mitophagy
Live-cell imaging with fluorescent protein fusions:
Dual-color imaging of fluorescently tagged ATG32 and autophagy machinery components (ATG8, ATG11)
Time-lapse microscopy to capture the dynamics of complex formation and mitochondrial sequestration
FRET/FLIM approaches to measure protein-protein interactions in real-time
Correlative light and electron microscopy (CLEM):
Combine fluorescence microscopy of tagged ATG32 with electron microscopy to visualize ultrastructural details
Immunogold labeling to precisely localize ATG32 relative to forming autophagosomes
Single-molecule techniques:
Single-molecule tracking to measure ATG32 mobility in the mitochondrial membrane
Single-molecule pull-down assays to determine the stoichiometry of ATG32-ATG8-ATG11 complexes
Expansion microscopy:
Physical expansion of specimens to achieve super-resolution imaging with conventional microscopes
Could reveal spatial relationships between ATG32 and other mitochondrial proteins
These advanced imaging approaches would help address how ATG32 is distributed on the mitochondrial surface, how it clusters during mitophagy initiation, and how it recruits the autophagy machinery to form the initiator complex described in biochemical studies .
Understanding ATG32 function has significant implications for research on mitochondrial diseases:
Therapeutic target development:
Identifying functional equivalents of ATG32 in human cells could provide targets for modulating mitophagy
Enhancing mitophagy could help clear damaged mitochondria in diseases characterized by mitochondrial dysfunction
Engineering ATG32-inspired synthetic receptors could allow targeted removal of specific mitochondrial populations
Diagnostic applications:
Understanding the molecular mechanisms of mitophagy could lead to biomarkers for mitochondrial quality control defects
Assays based on mitophagy receptor function could help identify mitochondrial turnover abnormalities
Disease modeling:
Cross-species conservation insights:
Drug discovery platforms:
Recombinant ATG32 proteins could be used in high-throughput screening assays to identify compounds that modulate mitophagy
Structure-based drug design targeting the interfaces between mitophagy receptors and autophagy machinery